Search results

I början av 1970-talet klev Lars Edvinsson för första gången in genom dörrarna på Lunds universitet. Då som nyantagen läkarstudent och nyfiken blivande forskare på Histologen på Biskopsgatan. Drygt 50 år senare tilldelas han världens mest prestigefyllda pris inom hjärnforskning, ”The Brain Prize”, som varje år delas ut av Lundbeckfonden. Han får priset för sin banbrytande forskning om migrän. – De

https://www.medicin.lu.se/artikel/migran-pionjar-far-varldens-storsta-pris-inom-hjarnforskning - 2025-12-27

Syfte: Studera om RhinoChill, en kylanordning som i dag används för att kyla ned vid stroke och hjärtstopp, också kan användas i hemmiljö för att lindra smärta och andra migränsymtom. Nedkylning som behandling av migrän Tidigare studier genomförda på sjukhus har visat att nedkylning via näsans slemhinnor kan fungera som behandling mot migränbesvär. Forskarna vill nu undersöka om behandlingsmetoden

https://www.medicin.lu.se/artikel/annons-personer-i-skane-med-migran-sokes-till-studie-med-egenbehandling-i-hemmet-1 - 2025-12-27

Forskare vid Lunds universitet visar att en ny undersökningsmetod vid hjärtinfarkt eller andra hjärtbesvär, kan identifiera fettrik plack i blodkärlen runt hjärtat som inte går att se med traditionell kranskärlsröntgen. Det är plack som senare kan orsaka patienten en ny hjärtinfarkt eller kärlkramp. Studien publiceras nu i den vetenskapliga tidskriften The Lancet. – Vi har arbetat med den här stud

https://www.medicin.lu.se/artikel/minskad-risk-aterfall-i-hjartinfarkt-med-ny-undersokningsmetod - 2025-12-27

Docent Albert Salehi och professor Claes Wollheim vid Lunds universitets Diabetescentrum får genom sitt företag Abarceo Pharma 21,5 miljoner kronor, varav 7,5 miljoner kommer från Almi Invest, resten från privata investerare. Företaget håller på att utveckla ett läkemedel som ska bromsa utvecklingen av typ 2-diabetes i ett tidigt stadium och planerar inleda de första kliniska studierna 2024. Gratu

https://www.medicin.lu.se/artikel/215-miljoner-till-utveckling-av-lakemedel-mot-typ-2-diabetes - 2025-12-27

Många patienter som söker vård för långvarig höft- och ljumsksmärta blir remitterade till ortopedkirurgen. Sjukgymnasten Anders Pålssons doktorsavhandling från Lunds universitet visar att patienterna upplever låg livskvalitet och har låg fysisk funktion. Om smärtan kan ringas in och diagnosticeras redan på vårdcentralen kan patienternas dryga väntan på rätt behandling kortas. Det finns olika slags

https://www.medicin.lu.se/artikel/tidigare-diagnostik-ger-kortare-koer-till-ortopeden - 2025-12-27

Artikeln är skriven mars 2020 i samband med familjeträffen. Det är en vacker om än något kylig lördagsmorgon i början av mars. Till Pastellens lokaler på SUS i Lund börjar barn och föräldrar droppa in lagom till att fikan dukas upp. Vid dörren står barnkirurg och docent Pernilla Stenström och hälsar välkommen och hejar igenkännande. Många av barnen som kommer hit idag är patienter till henne som h

https://www.medicin.lu.se/artikel/familjedag-med-tarmen-i-fokus-hirschsprungs-sjukdom - 2025-12-27

Jan Sundquist, professor i allmänmedicin vid Centrum för Primärvårdsforskning har tilldelats 3 miljoner dollar av National Institutes of Health, NIH, USA. Tillsammans med professor Kenneth Kendler vid Virginia Commonwealth University ska forskargruppen bland annat studera hur individuella faktorer och miljöfaktorer samverkat över tid vid uppkomsten av den pågående opioidepidemin och annat drogmiss

https://www.medicin.lu.se/artikel/arv-och-miljo-betydelse-opioidepidemin-och-drogmissbruk - 2025-12-27

Parkinsons sjukdom utvecklas i takt med att hjärnans nervceller bryts ner. Nedbrytningen orsakas av skadliga ansamlingar av proteinet alfa-synuklein. Nu har forskar vid Lunds universitet i samarbete med europeiska kollegor fått en ökad förståelse för hur dessa ansamlingar, proteinaggregat, uppstår. Resultaten publiceras i Cell Reports. Hjärnan består av miljarder nervceller som för att fungera är

https://www.medicin.lu.se/artikel/nya-ron-om-astrocyternas-roll-vid-parkinson - 2025-12-27

A large international study has identified three different pathways towards type 1 diabetes in children. Researchers at Lund University Diabetes Centre have contributed with data from a prospective study in southern Sweden. An important objective with the study published in Nature Communications is to gain a better understanding of how the disease develops to be able to take preventive measures. “

https://www.ludc.lu.se/article/large-international-study-points-three-pathways-towards-type-1-diabetes - 2025-12-27

Researchers at Lund University have discovered increased levels of a microRNA in type 2 diabetes, which has a negative effect on insulin secretion. Their experiments on human insulin producing cells in the pancreas also demonstrate that it is possible to increase the insulin secretion by reducing the levels of this microRNA. An important goal of the research is to develop new treatments for people

https://www.ludc.lu.se/article/newly-discovered-drug-candidate-increases-insulin-secretion-type-2-diabetes - 2025-12-27

Obesity and excess weight increase the risk of developing type 2 diabetes, but individuals of normal weight can also develop the disease. Researchers at Lund University have discovered that it is possible to identify at-risk individuals by measuring BMI in a new way. The authors of the study have identified metabolic alterations associated with obesity that can increase the risk of developing type

https://www.ludc.lu.se/article/new-way-measuring-bmi-can-predict-risk-type-2-diabetes-individuals-normal-weight - 2025-12-27

A new study by researchers at Lund University supports the notion that patients with type 2 diabetes should be divided into subgroups and given individualised treatment. The study demonstrates that there are distinct epigenetic differences between different groups of patients with type 2 diabetes. The epigenetic markers were also associated with different risks of developing common complications i

https://www.ludc.lu.se/article/epigenetic-markers-predict-complications-patients-type-2-diabetes - 2025-12-27

Epigenetics has become an important tool for researchers endeavoring to understand the causes and development stages of type 2 diabetes. In the future, epigenetic biomarkers could be used to predict type 2 diabetes and individualise its treatment. Diabetes and epigenetics researchers at Lund University summarise some of the most important advancements in a review article published in Nature Review

https://www.ludc.lu.se/article/epigenetics-can-pave-way-individualised-treatment-type-2-diabetes - 2025-12-27

Insulin secretion into the bloodstream requires a protein called CD59. New research led by Lund University shows that the two protein variants that are responsible for this function of CD59 are affected in diabetes. The study has been recently published in PNAS. Insulin affects many bodily functions, and is required for survival. It causes cells to take up glucose from the blood, storage of energy

https://www.ludc.lu.se/article/newly-discovered-protein-variants-are-key-insulin-secretion - 2025-12-27

Why do some people develop type 1 diabetes and others do not? Worldwide, researchers are now collaborating to find the answer to this complex question. Diabetes researchers at Lund University recently contributed data to a new study that shows that type 1 diabetes develops in three different ways in children. This improved understanding makes it possible for scientists to conduct new types of stud

https://www.ludc.lu.se/article/blood-testing-children-leads-better-understanding-type-1-diabetes - 2025-12-27

Three researchers at Lund University Diabetes Centre (LUDC) have each been awarded a project grant of 47,500 euro by the Hjelt Diabetes Foundation. The aim of all three projects is to improve our understanding of diabetes and ultimately enable better treatments of type 2 diabetes and its complications. One of the three projects uses advanced technology to learn more about the mechanisms behind dia

https://www.ludc.lu.se/article/new-funding-hjelt-diabetes-foundation-improve-understanding-diabetes - 2025-12-27

Impaired insulin secretion is closely associated with type 2 diabetes, but the process is not yet fully understood. A new study by researchers at Lund University shows that the Piezo1 ion channel regulates insulin secretion, which means it may be an important target for new diabetes treatments. Type 2 diabetes often occurs because the pancreatic beta cells are unable to produce enough effective in

https://www.ludc.lu.se/article/study-shows-piezo1-ion-channel-plays-important-role-insulin-secretion - 2025-12-27

We were interested to know what our Scientific Advisory Board think about the research currently underway at Lund University Diabetes Centre (LUDC), and invited Flemming Pociot and Søren Brunak from the board to the LUDC retreat in Helsingborg recently. They spent their time at the retreat listening to presentations and getting updates, and were able to provide valuable feedback. A presentation ab

https://www.ludc.lu.se/article/scientific-advisory-board-we-hope-see-more-data-about-subgroups - 2025-12-27

A large-scale faeces and blood sample study indicates strong associations between gut bacteria and metabolites in the blood. Among other findings, the research team behind the study has identified new associations between a common type 2 diabetes drug and the gut microbiome. The study was led by researchers at Uppsala University and Lund University. The role of the gut microbiome in disease and he

https://www.ludc.lu.se/article/gut-microbiome-research-indicates-new-bacteria-and-metformin-associations - 2025-12-27

Since Helena Elding Larsson began her career as a diabetes researcher and paediatrician, she has seen many improvements in the care of patients with diabetes. Her own research focuses on the prevention of the development of type 1 diabetes. Helena Elding Larsson is this year’s recipient of the Medeon stipend, and she will be speaking at the World Diabetes Day Skåne event, in Malmö on November 12th

https://www.ludc.lu.se/article/diabetes-researcher-helena-elding-larsson-wants-prevent-type-1-diabetes-developing - 2025-12-27